Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure
AssigneeZensun (Shanghai) Science & Technology, Co., Ltd.
InventorMingdong Zhou
Life of this patent
Estimating the term…
Abstract
Disclosed are the use of neuregulin proteins in preparing a medicine for preventing, treating or delaying preserved ejection fraction cardiac failure in mammals, and a method for using the medicine. Also provided in the present invention is a method for preventing, treating or delaying preserved ejection fraction cardiac failure in mammals, comprising using the medication containing the neuregulin proteins in a special population having the disease or being at risk of having the disease.
Claims7
1-4. (canceled)
A pharmaceutical preparation for preventing, treating or delaying heart failure with preserved ejection fraction in a mammal, which comprises an effective amount of NRG.
Dependencies are inferred from the claim text.